Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REOLYSIN + Gemcitabine in Advanced Pancreatic Cancer
NCT00998322Phase 2Completed
- Sponsor
- Oncolytics Biotech Inc.
- Start
- Oct 2009
- Primary completion
- Dec 2013
- Modality
- Oncolytic Viruses, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pelareorep in pancreatic adenocarcinoma (PDAC), sponsored by Oncolytics Biotech Inc.. Started Oct 2009; status: completed.
02
Drugs
pelareorep
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00998322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00998322.